Abstract
Thirteen imipramine-like antidepressants and three anticholinergics potentiated yohimbine toxicity in mice. The strongest potentiation was observed after the nonantidepressant adrenergic compound AW 151129. Monomethyl derivatives were significantly stronger than their parent dimethyl compounds. Quaternary imipramine and amitriptyline, amphetamine, and inhibitors of monoamine oxidase were inactive. Pretreatment with an inhibitor of tyrosine hydroxylase (α-methyl-p-tyrosine) or the β-adrenergic-blocking drug pindolol diminished lethality in mice treated with a combination of desmethylimipramine (AW 151129) and yohimbine. The inhibitor of brain serotonin synthesis p-chlorophenylalanine and a depletor of serotonin and catecholamine synthesis, reserpine, enhanced yohimbine toxicity whereas serotonin and its precursors tryptophan and 5-hydroxytryptophan pro-longed survival time. Thus, a test of yohimbine potentiation toxicity in mice reveals an adrenergic component of pharmacological activity of antidepressants. The predictive value of this test is limited similarly to antihypothermic tests of antagonism to reserpine and the related drugs apomorphine and 5-hydroxytryptophan.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Callingham, B. A.: The effects of imipramine and related compounds on the uptake of noradrenaline into sympathetic nerve endings. In: Antidepressant drugs, S. Garattini, M. N. G. Dukes, eds., pp. 35–43. Amsterdam: Excerpta Medica 1967
Duane, S. R., Kubena, R. K., Barry, H.: Inactivity of Δ 9-tetrahydrocannabinol in antidepressant screening tests. Psychopharmacologia 31, 121–130 (1973)
Lapin, I. P., ed.: Experimental studies on antidepressants. Leningrad 1968
Lapin, I. P.: Pharmacological activity of quaternary derivatives of imipramine and diethylaminopropionyl-iminodibenzyl. Pharmakopsychiatr. Neuropsychopharmakol. 2, 14–27 (1969)
Lapin, I. P., Oxenkrug, G. F.: Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet 1969I, 132–136
Lapin, I. P., Oxenkrug, G. F., Ryzhov, I. V., Nikiforov, V. A.: Potentiation of the reserpine action in frogs as a characteristic effect of antidepressants. Farmakol. Toksikol. 39, 144–147 (1976)
Lapin, I. P., Samsonova, M. L.: Apomorphine-induced hypothermia in mice and the effect thereon of adrenergic and serotonergic agents. Farmakol. Toksikol. 31, 566–570 (1968)
Papeschi, R.: An investigation on the behavioral and hypothermic effects of yohimbine: Interaction with drugs affecting central and peripheral monoamines. Arch. Int. Pharmacodyn. Ther. 208, 61–80 (1974)
Papeschi, R., Sourkes, T. L.: Effect of yohimbine on brain 5-HT in relation to the action of antidepressants. Fifth World Congress of Psychiat. p. 457 (1971)
Quinton, R. M.: The increase in the toxicity of yohimbine induced by imipramine and other drugs in mice. Br. J. Pharmacol. 21, 51–66 (1963)
Ross, S. B., Renyi, A. L.: Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. Eur. J. Pharmacol. 2, 181–186 (1967)
Sanghvi, I., Gershon, S.: Yohimbine: Behavioral and biochemical effects in mice. Arch. Int. Pharmacodyn. Ther. 210, 108–120 (1974)
Schelkunov, E. L.: Pharmacological effects of apomorphine in mice as the tests for differentiation of antidepressants, cholinolytics and neuroleptics. Farmakol. Toksikol. 31, 559–563 (1968)
Schelkunov, E. L.: 5-Hydroxytryptophan-produced hypothermia in mice as a test for pharmacological differentiation of antidepressants, anticholinergics and neuroleptics: some data on the nature of this hypothermia. In: Serotonergic processes in the action of psychotropic drugs, I. P. Lapin, ed., pp. 150–176. Leningrad 1970
Schelkunov, E. L.: Efficacy of neuroleptics and antidepressants in the test of apomorphine hypothermia and some data concerning neurochemical mechanisms of the test. Psychopharmacology 55, 87–95 (1977)
Shimizu, M., Hirooka, T., Karasawa, T., Masuda, Y., Oka, M., Ito, T., Kamei, C., Sohji, Y., Hori, M., Yoshida, K., Kaneko, H.: Pharmacological evaluation of 3-(N-3,3-diphenylpropyl-N-methyl)-aminopropan-I-d-hydrochloride (PF-82), a new type of antidepressant drug. Arzneim. Forsch. 24, 166–173 (1974)
Simon, P., Boissier, J. R.: Evaluating potential antidepressants in animals. Int. J. Med. Res. 3, 14–17 (1975)
Stille, G., Lauener, H., Eichenberger, E., Matussek, N., Pöldinger, W.: Observations concerning adrenergic functions and antidepressant activity. Pharmakopsychiatr. Neuropsychopharmakol. 1, 123–135 (1968)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lapin, I.P. Adrenergic nonspecific potentiation of yohimbine toxicity in mice by antidepressants and related drugs and antiyohimbine action of antiadrenergic and serotonergic drugs. Psychopharmacology 70, 179–185 (1980). https://doi.org/10.1007/BF00435311
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00435311